MetaCap

Evogene Statistics

NASDAQ: EVGNIndustrialsAgricultural ChemicalsUSD

0.3162+0.0032 (+1.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Evogene by the numbers

Evogene has a market capitalization of $5.7 million based on 18.05M shares outstanding. With trailing EPS of $-1.55, Evogene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.6% below its 50-day average and 48.3% below its 200-day average.

Average daily trading volume is 1.40M shares, or about $443,939 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EVGN valuation vs. peer median

EVGN compared with the median of 8 peer companies
MetricEVGNPeer medianDifference
Market cap$5.71M$9.09M-37%
Avg. volume1.40M355.59K+295%

Peer median across 8 companies: SNES, FRTT, NXTS, BIOX, ICL, UAN, AVD, CBUS.

Valuation

Price / sales (latest FY)
1.48
EPS (TTM)
$-1.55

Price and trading

Previous close
0.313
Open
0.31
Day range
0.2891 – 0.341
52-week range
0.25 – 1.26
Beta
—
Volume
62.77K

Dividends and events

Annual dividend
None
Next earnings date
Nov 19, 2026

Additional statistics

Market Cap
5.71M
Forward Pe
-0.53
Eps
-1.55
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.26
Week52 Low
0.25
Avg Volume
1.40M
Shares Outstanding
18.05M
Ma50
0.39
Ma200
0.61
Earnings Date
Nov 19, 2026
Pct From52w High
-74.90%
Pct From52w Low
26.48%

Related